Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Lorch

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Plos One|September 16, 2016
Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled TrialJörg Täubel, Georg Ferber, Sara Fernandes, et al.
Journal of Clinical Pharmacology|April 3, 2014
Analyzing the relationship of QT interval and exposure to nitazoxanide, a prospective candidate for influenza antiviral therapy--A formal TQT studyJörg Täubel, Ulrike Lorch, Jean-François Rossignol, et al.
British Journal of Clinical Pharmacology|May 30, 2013
Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjectsJorg Taubel, Georg Ferber, Ulrike Lorch, et al.
British Journal of Clinical Pharmacology|September 14, 2016
Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjectsJörg Täubel, Georg Ferber, Gabriel Fox, et al.
British Journal of Clinical Pharmacology|March 21, 2019
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasoneOliver Pohl, Line Marchand, Jean-Pierre Gotteland, et al.
Plos One|August 21, 2015
Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay SensitivityJörg Täubel, Georg Ferber, Ulrike Lorch, et al.
British Journal of Clinical Pharmacology|May 1, 2018
Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal womenOliver Pohl, Line Marchand, Jean-Pierre Gotteland, et al.
British Journal of Clinical Pharmacology|January 31, 2012
Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteersJorg Taubel, Asif Naseem, Duolao Wang, et al.
Frontiers in Pharmacology|April 2, 2020
Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I TrialsSimon Coates, Duolao Wang, Tomasz Pierscionek, et al.
British Journal of Clinical Pharmacology|April 22, 2010
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteersJorg Taubel, Asif Naseem, Tomohiko Harada, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Plos One|September 16, 2016
Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled TrialJörg Täubel, Georg Ferber, Sara Fernandes, et al.
Journal of Clinical Pharmacology|April 3, 2014
Analyzing the relationship of QT interval and exposure to nitazoxanide, a prospective candidate for influenza antiviral therapy--A formal TQT studyJörg Täubel, Ulrike Lorch, Jean-François Rossignol, et al.
British Journal of Clinical Pharmacology|May 30, 2013
Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjectsJorg Taubel, Georg Ferber, Ulrike Lorch, et al.
British Journal of Clinical Pharmacology|September 14, 2016
Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjectsJörg Täubel, Georg Ferber, Gabriel Fox, et al.
British Journal of Clinical Pharmacology|March 21, 2019
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasoneOliver Pohl, Line Marchand, Jean-Pierre Gotteland, et al.
Plos One|August 21, 2015
Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay SensitivityJörg Täubel, Georg Ferber, Ulrike Lorch, et al.
British Journal of Clinical Pharmacology|May 1, 2018
Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal womenOliver Pohl, Line Marchand, Jean-Pierre Gotteland, et al.
British Journal of Clinical Pharmacology|January 31, 2012
Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteersJorg Taubel, Asif Naseem, Duolao Wang, et al.
Frontiers in Pharmacology|April 2, 2020
Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I TrialsSimon Coates, Duolao Wang, Tomasz Pierscionek, et al.
British Journal of Clinical Pharmacology|April 22, 2010
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteersJorg Taubel, Asif Naseem, Tomohiko Harada, et al.
Pageof 5